Skip to main content
Clinical Trials/NCT02135211
NCT02135211
Completed
N/A

Feasibility and Acceptability of a Lifestyle Intervention for Patients Receiving Surgical Treatment for Lung Surgery

Dana-Farber Cancer Institute2 sites in 1 country42 target enrollmentSeptember 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Carcinoma, Non Small Cell Lung
Sponsor
Dana-Farber Cancer Institute
Enrollment
42
Locations
2
Primary Endpoint
Feasibility and acceptability
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The objective of this proposal is to test the feasibility and acceptability of a lifestyle risk reduction intervention for patients with lung cancer receiving surgical treatment. This study will provide the preliminary data needed to conduct a larger randomized controlled trial that tests an innovative, multidisciplinary intervention that has the potential to transform the standard of care for patients receiving surgical treatment for lung cancer.

Registry
clinicaltrials.gov
Start Date
September 2012
End Date
June 2015
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mary E. Cooley, Phd

Nurse Scientist, PhD, CRNP, FAAN

Dana-Farber Cancer Institute

Eligibility Criteria

Inclusion Criteria

  • \> 21 years of age
  • English speaking
  • MD approval to participate in study
  • Meets one of the inclusions below:
  • a histological diagnosis of NSCLC undergoing potentially curative treatment
  • OR those undergoing surgical procedures for lung cancer (includes patients undergoing diagnostic testing or those presenting with lung nodules
  • 3.OR patients who have had a surgical procedure for lung cancer within the last six months.
  • May invite a buddy to join study with them defined as a friend, partner, adult child or sibling
  • Buddy Inclusion Criteria:
  • ≥ 21 years of age,

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Feasibility and acceptability

Time Frame: at end of study (4 months post intervention)

The primary outcome measures to establish feasibility and acceptability of the intervention for this study completion of nurse-patient contacts.

Secondary Outcomes

  • Interest for this study(baseline, 1 month, & 4 month)

Study Sites (2)

Loading locations...

Similar Trials